作者：
Eric,Chevet [1]
;
F,Bassal [2]
;
Stéphanie,Beq [3]
;
Benjamin,Bonhomme [4]
;
Emeric,Boisteau [4]
;
Julien,Calloch [5]
;
Dominique,Cazals-Hatem [6]
;
Frederic,Delom [7]
;
Delphine,Fessart [4]
;
Serge,Evrard [8]
;
Roman,Hrstka [9]
;
Ted,Hupp [10]
;
Astrid,Lièvre [9]
;
Edouard,Louis [10]
;
Jeremie,Mariau [5]
;
Marie-Alice,Meuwis [9]
;
Eric,Ogier-Denis [11]
;
Valerie,Paradis [12]
;
Simon,Pernot [7]
;
R,Pineau [13]
;
Xavier,Treton [4]
;
Valerie,Velasco [13]
;
Sophie,Vieujean [6]
作者单位：
U1242, INSERM, Rennes, France Eric.chevet@inserm.fr.
[1]
Centre de Lutte Contre le Cancer Eugene Marquis, Rennes, France.
[2]
University of Rennes, Rennes, France.
[3]
Thabor Therapeutics, Paris, France.
[4]
Institut Bergonié, Bordeaux, France.
[5]
U1242, INSERM, Rennes, France.
[6]
Department of Gastroenterology, CHU Rennes, Rennes, France.
[7]
Gastroenterology, IBD and intestinal failure department, Beaujon Hospital, Clichy, France.
[8]
Bordeaux II University, Talence, France.
[9]
U1312, INSERM, Bordeaux, France.
[10]
Masaryk Memorial Cancer Institute, Brno, Czech Republic.
[11]
University of Edinbhurg, Edinburgh, UK.
[12]
Hepato-gastroenterology and digestive oncology, University Hospital CHU of Liège and laboratory of translational gastroenterology, GIGA institute, ULiège, Liège, Belgium.
[13]
Pathology, Assistance Publique-Hôpitaux de Paris (AP-HP), Clichy, France.
[14]
Gastroenterology Department, Hôpital Beaujon, MICI et Assistance Nutritive, APHP, Paris, France.
[15]
DOI
10.1136/gutjnl-2022-328739
PMID
36591613
发布时间
2024-02-16
换一批
换一批
